Product Description: BMS 488043 (BMS 043) is an orally active and well-tolerated inhibitor of the attachment of human immunodeficiency virus type 1 (HIV-1) to CD4+ lymphocytes[1].
Applications: COVID-19-anti-virus
Formula: C22H22N4O5
References: [1]George J Hanna, et al. Antiviral activity, pharmacokinetics, and safety of BMS-488043, a novel oral small-molecule HIV-1 attachment inhibitor, in HIV-1-infected subjects. Antimicrob Agents Chemother. 2011 Feb;55(2):722-8.
CAS Number: 452296-83-2
Molecular Weight: 422.43
Research Area: Infection; Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: HIV